Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Gastroesophageal Adenocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2enfortumab vedotin 2Tablets 2Exercise 2Acupuncture Therapy 2nicotinamide-beta-riboside 1Vitamin B Complex 1Thioctic Acid 1Tadalafil 1Single Person 1Rosuvastatin Calcium 1Omeprazole 1Memantine 1Massage 1Lenalidomide 1Gloves, Surgical 1Fish Oils 1Fenofibrate 1Exercise Therapy 1Dexamethasone 1Cryotherapy 1Corn Oil 1Control Groups 1Bortezomib 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Single Person × 1 year × Clear all
NCT07629700 2026-06-05

ENDEAVOR

University of Florence

Phase NA Not yet recruiting
40 enrolled
Genitourinary

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡